CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- SC 13D/A Stake Beneficial Ownership Report
- 4/A Grant or award 10% owner acquired 144,000 shares (grant or award)
- 4/A Grant or award Director acquired 144,000 shares (grant or award)
- 4 Grant or award 10% owner acquired 144,000 shares (grant or award)
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 144,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 45,000 shares (grant or award)
- 4 Grant or award 10% owner acquired 270,270 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 13,513 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Director acquired 27,027 shares (grant or award)
- 8-K Event Material agreement · Unregistered share sale
- 4 Grant or award Director acquired 135,135 shares (grant or award)
Page 22 of 63 · 1,250 filings